Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology

被引:0
作者
Duwe, Lea [1 ]
Fouassier, Laura [2 ]
Lafuente-Barquero, Juan [1 ]
Andersen, Jesper B. [1 ]
机构
[1] Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, Dept Hlth & Med Sci, DK-2200 Copenhagen N, Denmark
[2] Sorbonne Univ, Ctr Rech St Antoine, Inserm, CRSA, Paris, France
来源
TRANSLATIONAL ONCOLOGY | 2022年 / 26卷
基金
英国医学研究理事会;
关键词
Cholangiocarcinoma (CCA); Actin cytoskeleton; Polarization; Cell motility; Pathobiology; INTRAHEPATIC CHOLANGIOCARCINOMA; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; THERAPEUTIC TARGETS; HELICOBACTER-PYLORI; CELLULAR INVASION; POOR-PROGNOSIS; BETA-ACTIN; SINGLE-ARM; OPEN-LABEL;
D O I
10.1016/j.tranon.2022.101531
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Correct actin cytoskeleton organization is vital in the liver organ homeostasis and disease control. Rearrangements of the actin cytoskeleton may play a vital role in the bile duct cells cholangiocytes. An abnormal actin network leads to aberrant cell morphology, deregulated signaling networks and ultimately triggering the development of cholangiocarcinoma (CCA) and paving the route for cancer cell dissemination (metastasis). In this review, we will outline alterations of the actin cytoskeleton and the potential role of this dynamic network in initiating CCA, as well as regulating the course of this malignancy. Actin rearrangements not only occur because of signaling pathways, but also regulate and modify cellular signaling. This emphasizes the importance of the actin cytoskeleton itself as cause for aberrant signaling and in promoting tumorigenic phenotypes. We will highlight the impact of aberrant signaling networks on the actin cytoskeleton and its rearrangement as potential cause for CCA. Often, these exact mechanisms in CCA are limited understood and still must be elucidated. Indeed, focusing future research on how actin affects and regulates other signaling pathways may provide more insights into the mechanisms of CCA development, progression, and metastasis. Moreover, manipulation of the actin cytoskeleton organization highlights the potential for a novel therapeutic area.
引用
收藏
页数:13
相关论文
共 181 条
  • [1] The Extracellular Domain of Smoothened Regulates Ciliary Localization and Is Required for High-Level Hh Signaling
    Aanstad, Pia
    Santos, Nicole
    Corbit, Kevin C.
    Scherz, Paul J.
    Trinh, Le A.
    Salvenmoser, Willi
    Huisken, Jan
    Reiter, Jeremy F.
    Stainier, Didier Y. R.
    [J]. CURRENT BIOLOGY, 2009, 19 (12) : 1034 - 1039
  • [2] Actin-targeting natural products: structures, properties and mechanisms of action
    Allingham, J. S.
    Klenchin, V. A.
    Rayment, I.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (18) : 2119 - 2134
  • [3] First-in-Class Selective HDAC6 Inhibitor (ACY-1215) Has a Highly Favorable Safety Profile in Patients with Relapsed and Refractory Lymphoma
    Amengual, Jennifer E.
    Lue, Jennifer K.
    Ma, Helen
    Lichtenstein, Renee
    Shah, Bijal
    Cremers, Serge
    Jones, Simon
    Sawas, Ahmed
    [J]. ONCOLOGIST, 2021, 26 (03) : 184 - e366
  • [4] Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
    Andersen, Jesper B.
    Spee, Bart
    Blechacz, Boris R.
    Avital, Itzhak
    Komuta, Mina
    Barbour, Andrew
    Conner, Elizabeth A.
    Gillen, Matthew C.
    Roskams, Tania
    Roberts, Lewis R.
    Factor, Valentina M.
    Thorgeirsson, Snorri S.
    [J]. GASTROENTEROLOGY, 2012, 142 (04) : 1021 - U552
  • [5] The Role of the Hedgehog Pathway in Cholangiocarcinoma
    Anichini, Giulia
    Carrassa, Laura
    Stecca, Barbara
    Marra, Fabio
    Raggi, Chiara
    [J]. CANCERS, 2021, 13 (19)
  • [6] A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
    Aragona, Mariaceleste
    Panciera, Tito
    Manfrin, Andrea
    Giulitti, Stefano
    Michielin, Federica
    Elvassore, Nicola
    Dupont, Sirio
    Piccolo, Stefano
    [J]. CELL, 2013, 154 (05) : 1047 - 1059
  • [7] Fibroblast Growth Factor Receptor 2 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Cholangiocarcinoma
    Arai, Yasuhito
    Totoki, Yasushi
    Hosoda, Fumie
    Shirota, Tomoki
    Hama, Natsuko
    Nakamura, Hiromi
    Ojima, Hidenori
    Furuta, Koh
    Shimada, Kazuaki
    Okusaka, Takuji
    Kosuge, Tomoo
    Shibata, Tatsuhiro
    [J]. HEPATOLOGY, 2014, 59 (04) : 1427 - 1434
  • [8] Cholangiocarcinoma 2020: the next horizon in mechanisms and management
    Banales, Jesus M.
    Marin, Jose J. G.
    Lamarca, Angela
    Rodrigues, Pedro M.
    Khan, Shahid A.
    Roberts, Lewis R.
    Cardinale, Vincenzo
    Carpino, Guido
    Andersen, Jesper B.
    Braconi, Chiara
    Calvisi, Diego F.
    Perugorria, Maria J.
    Fabris, Luca
    Boulter, Luke
    Macias, Rocio I. R.
    Gaudio, Eugenio
    Alvaro, Domenico
    Gradilone, Sergio A.
    Strazzabosco, Mario
    Marzioni, Marco
    Coulouarn, Cedric
    Fouassier, Laura
    Raggi, Chiara
    Invernizzi, Pietro
    Mertens, Joachim C.
    Moncsek, Anja
    Rizvi, Sumera
    Heimbach, Julie
    Koerkamp, Bas Groot
    Bruix, Jordi
    Forner, Alejandro
    Bridgewater, John
    Valle, Juan W.
    Gores, Gregory J.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (09) : 557 - 588
  • [9] Cholangiocyte pathobiology
    Banales, Jesus M.
    Huebert, Robert C.
    Karlsen, Tom
    Strazzabosco, Mario
    LaRusso, Nicholas F.
    Gores, Gregory J.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (05) : 269 - 281
  • [10] Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
    Berman, DM
    Karhadkar, SS
    Maitra, A
    de Oca, RM
    Gerstenblith, MR
    Briggs, K
    Parker, AR
    Shimada, Y
    Eshleman, JR
    Watkins, DN
    Beachy, PA
    [J]. NATURE, 2003, 425 (6960) : 846 - 851